SRI International DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Virtual Booth

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

4 News #PharmaBuzz

media
4 News #PharmaBuzz

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SRI is an independent, nonprofit research center that works with clients to take the most advanced R&D from the laboratory to the marketplace. Serving government and industry, we collaborate across technical and scientific disciplines to generate real innovation and create high value for our clients. We invent solutions that solve your most challenging problems today and look ahead to the needs of the future. For more than 70 years, we’ve led the discovery and design of ground-breaking products, technologies, and industries – from Siri and online banking to medical ultrasound, cancer treatments, and much more. Rock-solid R&D is at the core of everything we do, but what sets us apart is our ability to take our clients from idea generation all the way through to the end user. Clients benefit tremendously from SRI's breadth and depth, multidisciplinary teams and understanding of practical applications. As a nonprofit research institute, we are driven by impact, not shareholder value. Sponsored R&D is at the center of SRI’s integrated business models. The revenue generated by our R&D projects, commercialization activities, and marketplace solutions is reinvested in SRI capabilities, facilities, and staff to advance our mission and to continue to meet client and partner needs. No matter what the client or project, we focus on meeting client and market needs to create and deliver new value, whether the outcome is an R&D solution, technology license, new product or spin-off venture.

Tides AsiaTides Asia

Not Confirmed

Not Confirmed

24-26 February, 2026

Tokyo, Japan
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California
Biotech ShowcaseBiotech Showcase

Not Confirmed

Not Confirmed

12-14 January, 2026

San Diego, California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

U.S.A

Address

333 Ravenswood Avenue Menlo Park , CA 94025-3493

Telephone

+1 (650) 859-2000

enquiries@pharmacompass.com

Website

https://www.sri.com/

http://www.linkedin.com/company/sri-international

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

N4 Pharma, Sri International Collaborate: Nuvec® Nanoparticle

22 Sep 2025

// PHARMAWEB

SRI Names Kathlynn Brown Biosciences Division President

08 Feb 2023

// CONTRACT PHARMA

SRI International Appoints Kathlynn Brown to Biosciences Division President

31 Jan 2023

// BUSINESSWIRE

SRI International Announces Collaboration Agreement with Janssen

05 Jan 2022

// PRNEWSWIRE

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Company profile for SRI International